By continuing, you agree to the Terms of Service.
This website uses cookies to enhance your browsing experience. Learn More.
Essential Cookies
Optional Cookies
Login
Logo for company Jyong Biotech Ltd. Ordinary Shares

Jyong Biotech Ltd. Ordinary Shares (MENS)

NASDAQ Currency in USD
$60.95
-$3.47
-5.39%
Last Update: 12 Sept 2025, 14:39
$4.52B
Market Cap
0.00
P/E Ratio (TTM)
Forward Dividend Yield
$6.01 - $67.11
52 Week Range

MENS Stock Price Chart

Explore Jyong Biotech Ltd. Ordinary Shares interactive price chart. Choose custom timeframes to analyze MENS price movements and trends.

MENS Company Profile

Discover essential business fundamentals and corporate details for Jyong Biotech Ltd. Ordinary Shares (MENS) to support your stock research and investment decisions.

Sector

Healthcare

Industry

Biotechnology

IPO Date

17 Jun 2025

Employees

31.00

CEO

Kuo Fu-Feng

Description

Jyong Biotech Ltd. is a Taiwan-based biotech firm focused on developing and commercializing plant-derived drugs targeting urinary system diseases. The company operates through its subsidiaries—Health Ever Bio-Tech, Genvace, and others—working on drug candidates like MCS‑2 (for BPH) currently in Phase III, PCP (for prostate cancer) in Phase II, and IC in pre-clinical stages

MENS Financial Timeline

Browse a chronological timeline of Jyong Biotech Ltd. Ordinary Shares corporate events including earnings releases, dividend announcements, and stock splits.

No results found.

MENS Stock Performance

Access detailed MENS performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.

Explore Related Stocks

Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.

Discover More
Command Palette
Search for a command to run